Literature DB >> 19013762

Many vaginal microbicide trial participants acknowledged they had misreported sensitive sexual behavior in face-to-face interviews.

Abigail Norris Turner1, Alana E De Kock, Amy Meehan-Ritter, Kelly Blanchard, Mohlatlego H Sebola, Anwar A Hoosen, Nicol Coetzee, Charlotte Ellertson.   

Abstract

OBJECTIVE: We investigated whether participants in a phase II randomized clinical trial of a candidate vaginal microbicide ever intentionally misled interviewers. STUDY DESIGN AND
SETTING: We used audio computer-assisted self-interviews (ACASI) to ask the South African women (n=132) participating in the trial about the accuracy of self-reported data collected during face-to-face interviews. The trial protocol recommended that women use their assigned gel (active microbicide or placebo) with condoms during each vaginal sex act.
RESULTS: Nearly four-fifths of participants (n=104, 79%) reported that they had misinformed trial interviewers at least once. Motivations included politeness (n=45, 34% of ACASI participants) to avoid criticism or seek praise (n=32, 24%), and embarrassment (n=24, 18%). Participants acknowledged misreporting eligibility characteristics to enroll (11%) and, during follow-up, exaggerating their enthusiasm for the study gel (13%), applicator (13%), and the effect of the gel on sexual pleasure (13%). In general, women who were untruthful had actually used the gel with condoms less and used the gel alone more than they had reported during the trial. Women overwhelmingly found the computer survey easy.
CONCLUSION: Researchers cannot assume that participants always tell the truth about sensitive behaviors in face-to-face interviews. ACASI was efficient and acceptable in this population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19013762     DOI: 10.1016/j.jclinepi.2008.07.011

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  33 in total

Review 1.  Microbicides: topical prevention against HIV.

Authors:  Robin J Shattock; Zeda Rosenberg
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

2.  Expanded safety and acceptability of the candidate vaginal microbicide Carraguard® in South Africa.

Authors: 
Journal:  Contraception       Date:  2010-05-26       Impact factor: 3.375

3.  Reporting on first sexual experience: The importance of interviewer-respondent interaction.

Authors:  Michelle Poulin
Journal:  Demogr Res       Date:  2010-03-03

4.  Predictors of unprotected sex among female sex workers in Madagascar: comparing semen biomarkers and self-reported data.

Authors:  Maria F Gallo; Markus J Steiner; Marcia M Hobbs; Mark A Weaver; Theresa Hatzell Hoke; Kathleen Van Damme; Denise J Jamieson; Maurizio Macaluso
Journal:  AIDS Behav       Date:  2010-12

5.  Disclosure of microbicide gel use to sexual partners: influence on adherence in the CAPRISA 004 trial.

Authors:  Kathryn Therese Mngadi; Silvia Maarschalk; Anneke C Grobler; Leila E Mansoor; Janet A Frohlich; Bernadette Madlala; Nelisiwe Ngcobo; Salim S Abdool Karim; Quarraisha Abdool Karim
Journal:  AIDS Behav       Date:  2014-05

Review 6.  The validity of self-reported behaviors: methods for estimating underreporting of risk behaviors.

Authors:  Marlena S Norwood; James P Hughes; K Rivet Amico
Journal:  Ann Epidemiol       Date:  2016-08-08       Impact factor: 3.797

7.  Trypan blue staining to determine vaginal exposure in two types of plastic vaginal applicators containing two different microbicide formulations.

Authors:  Anke Hemmerling; William G Harrison; Joelle Morgan Brown; Barbara Moscicki; Maria Oziemkowska; Elizabeth A Bukusi; Craig R Cohen
Journal:  Sex Transm Dis       Date:  2012-09       Impact factor: 2.830

8.  Adherence and acceptability in MTN 001: a randomized cross-over trial of daily oral and topical tenofovir for HIV prevention in women.

Authors:  Alexandra M Minnis; Sharavi Gandham; Barbra A Richardson; Vijayanand Guddera; Beatrice A Chen; Robert Salata; Clemensia Nakabiito; Craig Hoesley; Jessica Justman; Lydia Soto-Torres; Karen Patterson; Kailazarid Gomez; Craig W Hendrix
Journal:  AIDS Behav       Date:  2013-02

9.  Adherence and the Lie in a HIV Prevention Clinical Trial.

Authors:  Jonathan Stadler; Fiona Scorgie; Ariane van der Straten; Eirik Saethre
Journal:  Med Anthropol       Date:  2015-11-17

10.  Hepatitis C virus and human immunodeficiency virus transmission routes: Differences and similarities.

Authors:  Francesca Cainelli
Journal:  World J Hepatol       Date:  2013-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.